Related Experiment Video

Updated: Jul 13, 2026

Detecting the Ligand-binding Domain Dimerization Activity of Estrogen Receptor Alpha Using the Mammalian Two-Hybrid Assay
09:07

Detecting the Ligand-binding Domain Dimerization Activity of Estrogen Receptor Alpha Using the Mammalian Two-Hybrid Assay

Published on: December 19, 2018

Progressive loss of estrogen receptor alpha cofactor recruitment in endocrine resistance

Catherine Naughton1, Kenneth MacLeod, Barbara Kuske

  • 1Edinburgh Cancer Research Centre, University of Edinburgh, Crewe Road South, Edinburgh EH4 2XR, United Kingdom. Catherine.Naughton@ed.ac.uk

Molecular Endocrinology (Baltimore, Md.)
|August 2, 2007
PubMed

Insights

Estrogen receptor-alpha (ERalpha) cofactors are crucial for endocrine-sensitive breast cancer. In endocrine-resistant breast cancer, cells progressively lose the need for these cofactors, altering gene regulation.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Differential expression of estrogen receptor-alpha (ERalpha) cofactors is linked to endocrine resistance in breast cancer.
  • Estrogen receptor-alpha (ERalpha) plays a key role in breast cancer progression and treatment response.

Purpose of the Study:

  • To investigate the role of ERalpha cofactors in the development of acquired endocrine resistance in breast cancer.
  • To elucidate the mechanisms by which breast cancer cells become resistant to endocrine therapy.

Main Methods:

  • Utilized a three-stage MCF-7 cell model simulating acquired endocrine resistance.
  • Employed chromatin immunoprecipitation and RNA interference techniques to analyze cofactor recruitment and expression.

Main Results:

  • Demonstrated a progressive loss of ERalpha cofactor recruitment to the estrogen-dependent pS2 gene during the development of endocrine resistance.
  • Observed a reduced requirement for cofactor expression in resistant cells, indicating altered gene regulation.
  • Identified a global loss of dependence on individual cofactors for proliferative cell growth in estrogen-resistant cells.

Conclusions:

  • The progressive loss of ERalpha cofactor recruitment and dependence represents a significant mechanism in acquired endocrine resistance in breast cancer.
  • Altered gene regulation due to reduced cofactor requirement may contribute to cancer progression.
  • Findings suggest potential therapeutic strategies targeting cofactor pathways in endocrine-resistant breast cancer.

More Related Videos

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer10:36

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer

Published on: March 17, 2016

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

Related Concept Videos

Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Menopause01:28

Menopause

Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
Endocrine Signaling01:45

Endocrine Signaling

Endocrine cells produce hormones to communicate with remote target cells found in other organs. The hormone reaches these distant areas using the circulatory system. This exposes the whole organism to the hormone but only those cells expressing hormone receptors or target cells are affected. Thus, endocrine signaling induces slow responses from its target cells but these effects also last longer.
Endocrine Signaling01:45

Endocrine Signaling

Endocrine cells produce hormones to communicate with remote target cells found in other organs. The hormone reaches these distant areas using the circulatory system. This exposes the whole organism to the hormone but only those cells expressing hormone receptors or target cells are affected. Thus, endocrine signaling induces slow responses from its target cells but these effects also last longer.
Target Cell Response to Hormones01:22

Target Cell Response to Hormones

Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...